Your browser doesn't support javascript.
loading
A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia.
Navada, Shyamala C; Fruchtman, Steven M; Odchimar-Reissig, Rosalie; Demakos, Erin P; Petrone, Michael E; Zbyszewski, Patrick S; Holland, James F; Silverman, Lewis R.
Afiliação
  • Navada SC; Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1079, New York, NY 10029, United States. Electronic address: shyamala.navada@mssm.edu.
  • Fruchtman SM; Onconova Therapeutics Inc., 375 Pheasant Run, Newtown, PA 18940, United States. Electronic address: sfruchtman@onconova.us.
  • Odchimar-Reissig R; Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1079, New York, NY 10029, United States. Electronic address: rosalie.odchimar-reissig@mssm.edu.
  • Demakos EP; Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1079, New York, NY 10029, United States. Electronic address: erin.demakos@mssm.edu.
  • Petrone ME; Onconova Therapeutics Inc., 375 Pheasant Run, Newtown, PA 18940, United States. Electronic address: mpetrone@onconova.us.
  • Zbyszewski PS; Onconova Therapeutics Inc., 375 Pheasant Run, Newtown, PA 18940, United States. Electronic address: pzbyszewski@onconova.us.
  • Holland JF; Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1079, New York, NY 10029, United States. Electronic address: james.holland@mssm.edu.
  • Silverman LR; Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1079, New York, NY 10029, United States. Electronic address: lewis.silverman@mssm.edu.
Leuk Res ; 64: 10-16, 2018 01.
Article em En | MEDLINE | ID: mdl-29144985

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonas / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Glicina / Antineoplásicos Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonas / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Glicina / Antineoplásicos Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article